Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT

被引：0
|
作者：
Shimoni, Avichai [1 ,2 ]
Labopin, Myriam [3 ]
Savani, Bipin N. [4 ]
Hamladji, Rose-Marie [5 ]
Beelen, Dietrich W. [6 ]
Mufti, Ghulam J. [7 ]
Socie, Gerard [8 ]
Delage, Jeremy [9 ]
Blaise, Didier [10 ]
Chevallier, Patrice [11 ]
Milpied, Noel [12 ,13 ]
Deconinck, Eric [14 ]
Mohty, Mohamad [15 ]
Nagler, Arnon [16 ]
机构：
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[3] Hop St Antoine, Serv Hematol & Therapie Cellulaire, Paris, France
[4] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA
[5] Ctr Pierre & Marie Curie, Algiers, Algeria
[6] Univ Hosp Essen, Dept Bone Marrow Transplantat, West German Canc Ctr, Essen, Germany
[7] Kings Coll London, Dept Haematol Med, London, England
[8] Hop St Louis, Dept Hematol BMT, Paris, France
[9] CHU Lapeyronie, Dept Hematol Clin, Montpellier, France
[10] Inst J Paoli I Calmettes, Ctr Rech Cancerol Marseille, Programme Transplantat Therapie Cellulaire, Marseille, France
[11] Nantes Univ Hosp, Dept Hematol, Nantes, France
[12] CHU Haut Leveque, Serv Hematol & Therapie Cellulaire, Bordeaux, France
[13] Univ Bordeaux, Bordeaux, France
[14] CHU Jean Minjoz, INSERM, UMR1098, Hematol, Besancon, France
[15] St Antoine Hosp, EBMT Paris Study Off, CEREST TC, Dept Haematol, Paris, France
[16] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Ramat Gan, Israel
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2280.2280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2280
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation
    Shimoni, Avichai
    Labopin, Myriam
    Savani, Bipin
    Hamladji, Rose-Marie
    Beelen, Dietrich
    Mufti, Ghulam
    Socie, Gerard
    Delage, Jeremy
    Blaise, Didier
    Chevallier, Patrice
    Forcade, Edouard
    Deconinck, Eric
    Mohty, Mohamad
    Nagler, Arnon
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 751 - 757
  • [2] Survival Advantage and Comparable Toxicity in Reduced Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation
    Sakellari, Ioanna
    Mallouri, Despina
    Gavriilaki, Eleni
    Batsis, Loannis
    Kaliou, Maria
    Constantinou, Varnavas
    Papalexandri, Apostolia
    Lalayanni, Chrysavgi
    Vadikolia, Chrysanthi
    Athanasiadou, Anastasia
    Yannaki, Evangelia
    Sotiropoulos, Damianos
    Smias, Christos
    Anagnostopoulos, Achilles
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 445 - 451
  • [3] Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
    Zinaida Peric
    Myriam Labopin
    Christophe Peczynski
    Emmanuelle Polge
    Jan Cornelissen
    Ben Carpenter
    Mike Potter
    Ram Malladi
    Jenny Byrne
    Harry Schouten
    Nathalie Fegueux
    Gerard Socié
    Montserrat Rovira
    Jurgen Kuball
    Maria Gilleece
    Sebastian Giebel
    Arnon Nagler
    Mohamad Mohty
    [J]. Bone Marrow Transplantation, 2020, 55 : 1560 - 1569
  • [4] Treosulfan-based compared to thiotepa-busulfan-fludarabine conditioning for haploidentical transplant in patients with acute myeloid leukemia. A study from the Acute Leukemia Working Party of the EBMT
    Saraceni, F.
    Labopin, M.
    Angelucci, E.
    Ciceri, F.
    Blaise, D.
    Remenyi, P.
    Sora, F.
    Apperley, J.
    Bramanti, S.
    Busca, A.
    Deconinck, E.
    Battipaglia, G.
    Visani, G.
    Socie, G.
    Bug, G.
    Mico, C.
    La Nasa, G.
    Musso, M.
    Olivieri, A.
    Spyridonidis, A.
    Savani, B.
    Nagler, A.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 36 - 37
  • [5] Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia
    Chen, Yi-Bin
    Coughlin, Erin
    Kennedy, Kevin F.
    Alyea, Edwin P.
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 981 - 987
  • [6] Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT
    Peric, Zinaida
    Labopin, Myriam
    Peczynski, Christophe
    Polge, Emmanuelle
    Cornelissen, Jan
    Carpenter, Ben
    Potter, Mike
    Malladi, Ram
    Byrne, Jenny
    Schouten, Harry
    Fegueux, Nathalie
    Socie, Gerard
    Rovira, Montserrat
    Kuball, Jurgen
    Gilleece, Maria
    Giebel, Sebastian
    Nagler, Arnon
    Mohty, Mohamad
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (08) : 1560 - 1569
  • [7] Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
    Lekakis, Lazaros
    de Lima, Marcos
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 785 - 798
  • [8] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Takuya Yamashita
    Akiyoshi Takami
    Naoyuki Uchida
    Takahiro Fukuda
    Tetsuya Eto
    Souichi Shiratori
    Shuichi Ota
    Takashi Akasaka
    Shigesaburo Miyakoshi
    Tadakazu Kondo
    Michihiro Hidaka
    Junya Kanda
    Yoshiko Atsuta
    Shingo Yano
    [J]. Bone Marrow Transplantation, 2020, 55 : 1955 - 1965
  • [9] Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan
    Yamashita, Takuya
    Takami, Akiyoshi
    Uchida, Naoyuki
    Fukuda, Takahiro
    Eto, Tetsuya
    Shiratori, Souichi
    Ota, Shuichi
    Akasaka, Takashi
    Miyakoshi, Shigesaburo
    Kondo, Tadakazu
    Hidaka, Michihiro
    Kanda, Junya
    Atsuta, Yoshiko
    Yano, Shingo
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (10) : 1955 - 1965
  • [10] FAVORABLE OUTCOMES OF REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH ACUTE LEUKEMIA
    Koh, K.
    Seo, J.
    Choi, E.
    Im, H.
    Seo, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 663 - 663
12345